Why the study?
It has been proposed that infection by adipogenic viruses constitutes a low risk factor for obesity, prompting investigation into adenovirus 36 presence, viral load, and genetic variability in fat tissue.
Is human adenovirus 36 infection associated with obesity and higher viral loads in visceral fat tissue?
Is human adenovirus 36 infection associated with obesity and higher viral loads in visceral fat tissue?
Human adenovirus 36 infection is significantly more prevalent and has a higher viral load in the visceral fat tissue of adults with obesity compared to normal-weight controls, suggesting it may be a significant risk factor for obesity.
Ad36 detection in obese adipose tissue is hypothesis-generating; leaves open causal contribution to human obesity.
It has been proposed that infection by adipogenic viruses constitutes a “low risk” factor for obesity. Here, we report the presence of adenovirus 36 (Ad36) and its viral load copy number in fat tissue of participants with obesity and normal weight; phylogenetic analysis was performed to describe their relationship and genetic variability among viral haplotypes. Adipose tissue obtained from 105 adult patients with obesity (cases) and 26 normal‐weight adult participants as controls were analyzed by quantitative polymerase chain reaction (qPCR) amplifying the partial Ad36 E1a gene. The amplicons were examined by melting curves and submitted to sequencing. Then, genetic diversity and phylogenetic inferences were performed. Ad36 was identified at rates of 82% and 46% in the case and control groups, respectively ( p = 1.1 × 10 −4 , odds ratio = 5.28); viral load copies were also significantly different between both groups, being 25% higher in the case group. Melting curve analysis showed clear amplification among positive samples. Phylogenetic inferences and genetic diversity analyses showed that the Ad36 E1a gene exhibits low genetic variability and differentiation with strong gene flow due to an expanding process. Our results suggest that the phenomenon of infectobesity by Ad36 might not be a low‐risk factor, as has been previously argued by other authors.
No takes yet. Share an insight, caveat, or question.
Sánchez-Aguillón et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: